HSBC Holdings’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-11,396
| Closed | -$45K | – | 2799 |
|
|
2024
Q3 | $45K | Sell |
11,396
-1,752
| -13% | -$6.92K | ﹤0.01% | 2500 |
|
|
2024
Q2 | $66.3K | Sell |
13,148
-29
| -0.2% | -$146 | ﹤0.01% | 2423 |
|
|
2024
Q1 | $69K | Buy |
13,177
+1,179
| +10% | +$6.18K | ﹤0.01% | 2483 |
|
|
2023
Q4 | $63K | Buy |
+11,998
| New | +$63K | ﹤0.01% | 2160 |
|
|
2021
Q1 | – | Sell |
-8,485
| Closed | -$394K | – | 2652 |
|
|
2020
Q4 | $394K | Sell |
8,485
-487
| -5% | -$22.6K | ﹤0.01% | 1951 |
|
|
2020
Q3 | $381K | Buy |
8,972
+1,351
| +18% | +$57.4K | ﹤0.01% | 1705 |
|
|
2020
Q2 | $366K | Buy |
7,621
+3,235
| +74% | +$155K | ﹤0.01% | 1671 |
|
|
2020
Q1 | $202K | Sell |
4,386
-552
| -11% | -$25.4K | ﹤0.01% | 1886 |
|
|
2019
Q4 | $297K | Sell |
4,938
-5,483
| -53% | -$330K | ﹤0.01% | 2020 |
|
|
2019
Q3 | $590K | Buy |
+10,421
| New | +$590K | ﹤0.01% | 1672 |
|